Continuing Medical Education (CME) Information |
| |
Program Purpose |
The program will help urologists evaluate current methodologies for early detection and diagnosis of bladder cancer, as well as strategize via case-based discussions the best treatment options for reducing morbidity and mortality. |
| |
Target Audience |
This activity is designed to meet the educational needs of urologists and other healthcare professionals interested in the management of bladder cancer patients. |
| |
Educational Objectives |
| After completing this activity, the participant should be able to:
- Identify detection, diagnostic and treatment challenges associated with urothelial carcinoma.
- Describe the variables that affect positive predictive value.
- Utilize strategies for dealing with tests that can identify disease earlier than they can be detected with standard imaging techniques.
|
| |
Accreditation Statement |
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Collaborative (MEC), Dane Garvin Ltd. and the Bladder Cancer Advisory Network (BCAN). Medical Education Collaborative is accredited by the ACCME to provide continuing medical education for physicians. |
| |
Credit Designation |
Medical Education Collaborative designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| |
Commercial Support Statement |
This program is funded by an educational grant from Abbott Molecular. |
| |
Faculty |
Chairman:
H.B. Grossman, MD
W. A. “Tex” and Deborah Moncrief, Jr.
Distinguished Chair in Urology
Professor and Deputy Chairman,
Department of Urology
The University of Texas
M. D. Anderson Cancer Center
C.P.N. Dinney, MD
Professor and Chairman, Department of Urology
The University of Texas
M.D. Anderson Cancer Center
J.S. Jones, MD
Vice Chairman, Glickman Urological Institute
Associate Professor of Surgery (Urology)
Louis S. Liou, MD, PhD
Director, Urologic Oncology Research
Department of Urology and Pathology
Boston University School of Medicine
Michael A. O'Donnell, MD
Professor, Director of Urologic Oncology
University of Iowa Department of Urology |
| |
Disclosure of Conflicts of Interests |
Medical Education Collaborative requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Medical Education Collaborative for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. |
| |
Faculty Disclosures |
| Name |
Type |
Commercial Supporter |
Colin P.N. Dinney, MD
(Planning Committee) |
1) Research Grants
2) Consultant
3) Speaker's Bureau |
1) AstraZeneca, GlaxoSmithKline, Canji/Schering-Plough
2) Abbott/Vysis, Novartis
3) Physicians Education Resource, Abbott/Vysis |
Louis S. Liou, M.D.
(Planning Committee) |
1) Speaker's Bureau
2) Consultant |
1) Abbott Molecular, Quest Diagnostics
2) Abbott Molecular, Quest Diagnostics, DiagnoCure |
Michael A. O'Donnell, MD
(Planning Committee) |
1) Research Grants
2) Consultant
3) Investigator
4) Speaker's Bureau |
1) Lilly
2) Lilly, Schering-Plough, Anadys, IDM, Viventia, Antigenics
3) Schering-Plough
4) Lilly, Antigenics |
| H. Barton Grossman, M.D. |
1) Scientific Advisory Board
2) Consultant
3) Investigator
4) Speaker's Bureau
5) Royalty |
1) Fujirebio Diagnostics, Inc
2) PhotoCure, Abbott Molecular
3) PhotoCure
4) GE Healthcare, Abbott Molecular, AstraZeneca
5) Dianon |
| J. Stephen Jones, M.D. |
None |
|
|
| Employees of Medical Education Collaborative, the accredited provider for this activity, have disclosed that they have no significant financial relationships. |
| |
How to Obtain Credit |
Viewers are expected to visit all presentations before attempting to take the test and activity evaluation. Successful completion will lead to the issuance of a certificate for 2.0 AMA PRA Category 1 Credit(s) TM . To receive credit, the course must be completed before July 2007.
If you attended the live presentation on May 19, 2006, and have received CME credit for this program, you are not eligible for additional credit.
Participation in this activity should be completed in approximately 2.0 hours.
Please follow these steps in order to receive CME credit for viewing the webcast:
-
Read all of the CME accreditation information above.
- View the complete webcast program.
- Click on the link to apply for CME credits.
- Complete the online registration (registration is free).
- Complete the online test and evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
- After successfully completing the online test and evaluation, you may view and print your online certificate.
Should you have any CME questions regarding this activity, please contact:
Medical Education Collaborative
651 Corporate Circle, Suite 104
Golden, CO 80401
866.420.3252 (toll free)
303.420.3259 (fax)
http://www.meccme.org/
For technical difficulties, please consult our Technical Instructions.
Release date: July 2006
Expiration date: July 2007 |
| |
| |
Program |
| If you have viewed all of the webcast presentations, click here to take the posttest. |
| |
| |
| |
|
